selected publications
- Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells. Immunity. 2024 Academic Article GET IT
- Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells. Nature immunology. 2024 Academic Article GET IT
-
A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design.
The Journal of experimental medicine.
2023
Academic Article
GET IT
Times cited: 3 -
Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition.
Immunity.
2022
Academic Article
GET IT
Times cited: 6 -
TCR-mimic bispecific antibodies to target the HIV-1 reservoir.
Proceedings of the National Academy of Sciences of the United States of America.
2022
Academic Article
GET IT
Times cited: 10 -
B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection.
PLoS pathogens.
2022
Academic Article
GET IT
Times cited: 5 -
Engaging innate immunity in HIV-1 cure strategies.
Nature reviews. Immunology.
2021
Review
GET IT
Times cited: 27 - Resolution of new daily persistent headache by a tumor necrosis factor alpha antagonist, Venlafaxine. 2019 GET IT